Interstrand cross-linking by Adriamycin in nuclear and mitochondrial DNA of MCF-7 cells

被引:54
作者
Cullinane, C [1 ]
Cutts, SM [1 ]
Panousis, C [1 ]
Phillips, DR [1 ]
机构
[1] La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia
关键词
D O I
10.1093/nar/28.4.1019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of Adriamycin by formaldehyde leads to the formation of drug-DNA adducts in vitro and these adducts stabilise the DNA to such a degree that they function as virtual interstrand cross-links. The formation of these virtual interstrand cross-links by Adriamycin was investigated in MCF-7 cells using a gene-specific interstrand cross-linking assay. Crosslinking was measured in both the nuclear-encoded DHFR gene and in mitochondrial DNA (mtDNA), Cross-link formation increased linearly with adriamycin concentration following a 4 h exposure to the drug. The rate of formation of adriamycin cross-links in each of the genomes was similar, reaching maximal levels: of 0.55 and 0.4 cross-links/10 kb in the DHFR gene and mtDNA respectively, following exposure to 20 mu M Adriamycin for 8 h. The interstrand cross-link was short lived in both DNA compartments, with a half-life of 4.5 and 3.3 h in the DHFR gene and mtDNa respectively. The kinetics of total Adriamycin adduct formation,:detected using [(14)C]Adriamycin, was similar to that of cross-link formation. Maximal adduct levels (30 lesions/10 kb) were observed following incubation at 20 mu M drug for 8 h. The formation of such high levels of adducts and cross-links could therefore be expected to contribute to the mechanism of action of Adriamycin.
引用
收藏
页码:1019 / 1025
页数:7
相关论文
共 39 条
[1]  
[Anonymous], [No title captured]
[2]  
[Anonymous], ENCY MOL BIOL
[3]  
CAPRANICO G, 1986, CANCER RES, V46, P5499
[4]   DOES ADRIAMYCIN INDUCE INTERSTRAND CROSS-LINKS IN DNA [J].
CULLINANE, C ;
VANROSMALEN, A ;
PHILLIPS, DR .
BIOCHEMISTRY, 1994, 33 (15) :4632-4638
[5]  
Cullinane C, 1998, CANCER RES, V58, P1400
[6]   INDUCTION OF STABLE TRANSCRIPTIONAL BLOCKAGE SITES BY ADRIAMYCIN - GPC SPECIFICITY OF APPARENT ADRIAMYCIN DNA ADDUCTS AND DEPENDENCE ON IRON(III) IONS [J].
CULLINANE, C ;
PHILLIPS, DR .
BIOCHEMISTRY, 1990, 29 (23) :5638-5646
[7]   THE CONSEQUENCES OF DOXORUBICIN QUINONE REDUCTION INVIVO IN TUMOR-TISSUE [J].
CUMMINGS, J ;
WILLMOTT, N ;
HOEY, BM ;
MARLEY, ES ;
SMYTH, JF .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (11) :2165-2174
[8]  
DEVITA VT, 1993, CANC PRINCIPLES PRAC, V1
[9]   Doxoform and daunoform: Anthracycline-formaldehyde conjugates toxic to resistant tumor cells [J].
Fenick, DJ ;
Taatjes, DJ ;
Koch, TH .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (16) :2452-2461
[10]   Growth arrest and non-apoptotic cell death associated with the suppression of c-myc expression in MCF-7 breast tumor cells following acute exposure to doxorubicin [J].
Fornari, FA ;
Jarvis, WD ;
Grant, S ;
Orr, MS ;
Randolph, JK ;
White, FKH ;
Gewirtz, DA .
BIOCHEMICAL PHARMACOLOGY, 1996, 51 (07) :931-940